Novanta Inc. (FRA:1GSN)

Market Cap	3.50B -21.3%
Revenue (ttm)	835.18M +3.3%
Net Income	45.85M -16.0%
EPS	1.25 -16.9%
Shares Out	n/a
PE Ratio	76.44
Forward PE	27.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	2
Open	102.00
Previous Close	101.00
Day's Range	102.00 - 102.00
52-Week Range	84.50 - 126.00
Beta	n/a
RSI	41.59
Earnings Date	May 5, 2026

About Novanta

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment s...

• Industry: Electronic Components, not elsewhere classified
• Founded: 1968
• Employees: 3,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1GSN

Financial Performance

In 2025, Novanta's revenue was $980.60 million, an increase of 3.30% compared to the previous year's $949.25 million. Earnings were $53.83 million, a decrease of -16.01%.

Financial numbers in USD